DnB Asset Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Sell |
12,904
-1,452
| -10% | -$23.2K | ﹤0.01% | 699 |
|
|
2025
Q1 | $245K | Buy |
14,356
+3,935
| +38% | +$67.2K | ﹤0.01% | 701 |
|
|
2024
Q4 | $258K | Sell |
10,421
-66
| -0.6% | -$1.64K | ﹤0.01% | 697 |
|
|
2024
Q3 | $299K | Buy |
10,487
+197
| +2% | +$5.62K | ﹤0.01% | 680 |
|
|
2024
Q2 | $271K | Buy |
10,290
+958
| +10% | +$25.3K | ﹤0.01% | 678 |
|
|
2024
Q1 | $302K | Buy |
+9,332
| New | +$302K | ﹤0.01% | 677 |
|